# A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

> **NCT02103595** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 80 (actual)

## Conditions studied

- Diabetes Mellitus Type 2, Diabetes Mellitus Type 1

## Interventions

- **DEVICE:** Accu-Chek FlexLink
- **DEVICE:** Accu-Chek FlexLink Plus

## Key facts

- **NCT ID:** NCT02103595
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-01
- **Primary completion:** 2014-06-30
- **Final completion:** 2014-06-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103595, "A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02103595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*